![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Immunologic adverse reactions of β-blockers and the skin - PMC
β-Blockers are important for dermatology as well, due to their potential adverse reactions. They share the ability to produce potentially severe adverse effects, especially in predisposed areas or areas of locus minoris resistentiae in the skin.
Why beta-blockers cause skin inflammation - ScienceDaily
2019年11月7日 · Beta-blockers are often used to treat high blood pressure and other cardiovascular diseases. However, in some patients they can trigger or exacerbate psoriasis, an inflammatory skin disease....
Understanding and Treating Beta-Blocker-Induced Skin Reactions …
2025年2月6日 · Discover how to diagnose and treat beta blocker rash effectively. Our blog provides insights into causes, prevention, and the role of sublingual immunotherapy in managing skin reactions.
Beta-blockers - DermNet
2020年7月26日 · Beta-blockers are medications that antagonize the effects of adrenaline and noradrenaline by blocking adrenergic receptors. Beta-blockers are used mainly for the treatment of cardiovascular diseases and glaucoma. Their use in dermatology is increasing for a variety of conditions. How do beta-blockers work?
Beta blocker allergy - American Academy of Allergy, Asthma
The skin rashes most commonly associated with beta-blockers include lichenoid eruptions, aggravation of pre-existing SLE, drug induced lupus, exacerbation of Raynaud’s, syndrome, xerosis with itching and photosensitivity reactions (Beltrani).
A recurring, itchy, burning rash in a patient taking beta-blockers
2014年12月15日 · Beta blockers are known to induce or aggravate psoriasis and should be avoided in patients with psoriasis when at all possible. The patient began narrowband ultraviolet B phototherapy (UVB) in...
Topical beta‐blockers in dermatologic therapy - PMC
Topical beta‐blockers are currently considered as an interesting alternative to oral administration for superficial thin hemangiomas. The most common topical beta‐blockers used in IHs are propranolol and timolol.
Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
We report a case of erythrodermic psoriasis caused by beta-blockers in a 61-year-old woman with no prior history of the skin condition. The diagnosis was made based on the characteristic histopathological picture and a Naranjo score of 6. She was administered 15 mg of methotrexate weekly and received supportive care.
Immunologic adverse reactions of β-blockers and the skin (Review)
While recent articles have focussed on the positive uses of β-blockers, it may also be wise to call our attention to the potential dermatologic adverse effects that may follow β-blocker use, as well as possible therapeutic approaches to these.
Immunologic adverse reactions of β-blockers and the skin
While recent articles have focussed on the positive uses of β-blockers, it may also be wise to call our attention to the potential dermatologic adverse effects that may follow β-blocker use, as well as possible therapeutic approaches to these.